BREAKTHROUGH HAEMOLYSIS

This adverse event was reported 399 times

These drugs are most commonly taken by patients reporting BREAKTHROUGH HAEMOLYSIS:

# Drug Count
0 RAVULIZUMAB 177
1 ECULIZUMAB 144
2 PEGCETACOPLAN 96
3 IPTACOPAN 37
4 DANICOPAN 23
5 FOLIC ACID 23
6 CROVALIMAB 10
7 CYCLOSPORINE 10
8 ACETAMINOPHEN 9
9 APIXABAN 9
See all common drugs associated with BREAKTHROUGH HAEMOLYSIS

BREAKTHROUGH HAEMOLYSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CROVALIMAB 10 0.0826
1 DANICOPAN 23 0.0742
2 PEGCETACOPLAN 96 0.0506
3 IPTACOPAN 37 0.0462
4 COUMARIN 1 0.0061
5 CHORIONIC GONADOTROPIN 3 0.0053
6 SUTIMLIMAB-JOME 1 0.0031
7 ECULIZUMAB 144 0.0026
8 PENICILLIN V POTASSIUM 4 0.0015
9 EQUINE THYMOCYTE IMMUNE GLOBULIN 1 0.0010
See all drugs enriched for association with BREAKTHROUGH HAEMOLYSIS